UnitedHealth UNH · NYSE
$418.08 -1.62% (-$6.90)
Summary
64 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 16 years in a row and pays out only 51% of profit.
- It holds more cash than debt: $28.5B against $5.62B.
- The share price is below the Bulios Fair Price.
- Revenue grew by 11% a year over the last 3 years.
What to watch
- Earnings per share fell by 15% a year over the last 3 years.
- Out of every 100 USD of revenue, only 3.5 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 24.0 USD for 1 USD of yearly profit. Over the last five years it was 26.5 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to grow by 0.1%. Earnings per share fell by 15% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 57 USD
- Sales and administration 38 USD
- Taxes and other 1.8 USD
- Net profit 3.5 USD
Net profit, industry median (Medical - Healthcare Plans) 2.3 USD
Out of every 100 USD of revenue, 3.5 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.13%
- Paid out of profit
- 51%
- Raised in a row
- 16 years
You receive $9.06 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 43
- Hold 7
- Sell 2
Today's price within the analysts' price targets
The average target of $471.33 is 13% above today's price. 83% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Premiums 79%
- Products 12%
- Services 8.5%
- Investment and other income 0.9%
By region
The company reports no revenue by region.
Premiums brings in 79% of revenue.
Segments in detail